New York, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nebulizer System Market, By Product Type, By Accessories, By Sales channel, By End Use, By ...

Dublin, Aug. 12, 2021 (GLOBE NEWSWIRE) -- The "Global Nebulizer System Market, By Product Type (Jet Nebulizer System, Mesh Nebulizer System, Ultrasonic Nebulizer System), By Accessories (Main ...

SUN-101 (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator delivered via the innovative, proprietary eFlow nebulizer closed system. Developed by PARI Pharma, eFlow is a ...

The global nebulizer market is projected to grow significantly, with its market size expected to reach USD 2.1 billion by 2032 from USD 1.2 billion in 2022, registering a compound annual growth rate ...

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, reports that the Israeli Patent Office (ILPO) ...

The MiniElite compressor nebulizer system is compact, lightweight, and designed for patient convenience. It can be powered by three versatile power sources- 110V AC, 12V DC (car) and an optional ...

Lonhala Magnair is available as a 25mcg strength inhalation solution per 1mL vial. Sunovion announced the launch of Lonhala Magnair (glycopyrrolate) inhalation solution for the long-term, maintenance ...

Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System Savara Inc. (Nasdaq: SVRA) (the Company), a clinical ...

A nebulizer transforms medicine into a breathable mist. The person inhales the mist, allowing the body to absorb the medicine quickly and effectively. In this article, we look at the benefits and uses ...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European Patent Office (EPO) ...